Aethlon Medical (AEMD) vs. Its Rivals Financial Analysis
Aethlon Medical (NASDAQ: AEMD) is one of 23 public companies in the “Analytical instruments” industry, but how does it contrast to its rivals? We will compare Aethlon Medical to similar companies based on the strength of its analyst recommendations, earnings, profitability, institutional ownership, risk, valuation and dividends.
Volatility & Risk
Aethlon Medical has a beta of 1.93, indicating that its stock price is 93% more volatile than the S&P 500. Comparatively, Aethlon Medical’s rivals have a beta of 1.10, indicating that their average stock price is 10% more volatile than the S&P 500.
7.4% of Aethlon Medical shares are owned by institutional investors. Comparatively, 62.9% of shares of all “Analytical instruments” companies are owned by institutional investors. 6.6% of Aethlon Medical shares are owned by company insiders. Comparatively, 14.7% of shares of all “Analytical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This is a summary of recent ratings and price targets for Aethlon Medical and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Aethlon Medical Competitors||119||738||1093||51||2.54|
Aethlon Medical currently has a consensus price target of $3.00, suggesting a potential upside of 200.00%. As a group, “Analytical instruments” companies have a potential upside of 2.66%. Given Aethlon Medical’s stronger consensus rating and higher possible upside, equities analysts clearly believe Aethlon Medical is more favorable than its rivals.
Earnings & Valuation
This table compares Aethlon Medical and its rivals gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Aethlon Medical||$150,000.00||-$5.67 million||-2.20|
|Aethlon Medical Competitors||$1.08 billion||$109.59 million||25.28|
Aethlon Medical’s rivals have higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This table compares Aethlon Medical and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Aethlon Medical Competitors||-190.83%||-33.65%||-15.46%|
Aethlon Medical rivals beat Aethlon Medical on 8 of the 13 factors compared.
Aethlon Medical Company Profile
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.